It is not too late to come in. This is a cheap price. The big thing left to go is FDA approval in regards to the NDA, then it will be too late. We are also due for a milestone payment early 2022.
Once we are approved within the US it will bring into play all the background setup and add value to ROW rights, other Phase 2 drugs in the pipeline, our current cash position, all the royalties and milestones. Everything will come to life, we just need FDA approval which judging by the results, looks to be all but guaranteed.
My valuation was around $5 to $10. Now I have realized what a gold mine this could be. If all of the above happens, I am quietly confident we are at $10 - $20.
Right now we are still around the phase 2 price before our ann with ACAD. It is not too late for those on the fence.
It is not too late to come in. This is a cheap price. The big...
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.97 |
Change
0.000(0.00%) |
Mkt cap ! $2.552B | |||
| Open | High | Low | Value | Volume |
| $19.96 | $19.97 | $19.69 | $4.156M | 209.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 246 | $19.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.99 | 512 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |